Welcome to our dedicated page for POSABIT SYSTEMS news (Ticker: $POSAF), a resource for investors and traders seeking the latest updates and insights on POSABIT SYSTEMS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect POSABIT SYSTEMS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of POSABIT SYSTEMS's position in the market.
POSaBIT Systems , trading as PBIT on the CSE and POSAF on the OTC, is expecting a delay in filing its 2023 annual financial statements by April 29, 2024, due to a change in auditors. The company aims to complete the filings by May 17, 2024, and has applied for a management cease trade order (MCTO) until then. The delay will postpone a scheduled conference call and webcast.